202 related articles for article (PubMed ID: 22818886)
1. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.
Rees M; Pérez-López FR; Ceasu I; Depypere H; Erel T; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; van der Schouw Y; Tremollieres F;
Maturitas; 2012 Oct; 73(2):171-4. PubMed ID: 22818886
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapies for postmenopausal vaginal atrophy.
Pickar JH
Maturitas; 2013 May; 75(1):3-6. PubMed ID: 23434231
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
[TBL] [Abstract][Full Text] [Related]
5. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
6. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
Goldstein I; Alexander JL
J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
[TBL] [Abstract][Full Text] [Related]
7. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
8. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
[TBL] [Abstract][Full Text] [Related]
9. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
[No Abstract] [Full Text] [Related]
10. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
11. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
Tan O; Bradshaw K; Carr BR
Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
[TBL] [Abstract][Full Text] [Related]
12. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
Bachmann G; Bobula J; Mirkin S
Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
[TBL] [Abstract][Full Text] [Related]
13. Vaginal DHEA to treat menopause related atrophy: a review of the evidence.
Panjari M; Davis SR
Maturitas; 2011 Sep; 70(1):22-5. PubMed ID: 21733647
[TBL] [Abstract][Full Text] [Related]
14. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide.
Hirschberg AL; Bitzer J; Cano A; Ceausu I; Chedraui P; Durmusoglu F; Erkkola R; Goulis DG; Kiesel L; Lopes P; Pines A; van Trotsenburg M; Lambrinoudaki I; Rees M
Maturitas; 2021 Jun; 148():55-61. PubMed ID: 33896654
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
Simon JA; Maamari RV
Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
[TBL] [Abstract][Full Text] [Related]
16. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
17. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
18. Recognizing and treating urogenital atrophy in postmenopausal women.
Goldstein I
J Womens Health (Larchmt); 2010 Mar; 19(3):425-32. PubMed ID: 20156082
[TBL] [Abstract][Full Text] [Related]
19. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.
Illston JD; Wheeler TL; Parker CR; Conner MG; Burgio KL; Goode PS; Richter HE
Maturitas; 2015 Aug; 81(4):475-9. PubMed ID: 26115591
[TBL] [Abstract][Full Text] [Related]
20. Vaginal atrophy. Managing vaginal dryness and irritation.
Mayo Clin Health Lett; 2012 Oct; 30(10):6. PubMed ID: 23133861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
